Peripheral intravenous noradrenaline administration
Vasopressor delivery · Shock / Sepsis
Physician-written · Verified by three sets of doctors · Reviewed November 2026
Bedside summary
Starting noradrenaline through a well-sited large peripheral cannula to avoid delaying vasopressor support while central access is obtained. Safe for short-term use with the right precautions; the main hazard is extravasation causing tissue necrosis.
Red flags
- Site blanching, pain, swelling or coolness (early extravasation)
- Escalating dose >0.5 mcg/kg/min via a peripheral line
- Distal pulse loss or digital ischaemia
- Cannula sited distally (hand/wrist/foot) or in a small vein
- Infusion running >6 h without central access plan
Assessment
Differential diagnosis
- Septic (distributive) shock
- Anaphylactic shock
- Post-induction / sedation-related vasoplegia
- Cardiogenic shock requiring pressor support
- Neurogenic shock
Investigations
- Lactate and venous/arterial blood gas
- Continuous invasive or frequent non-invasive BP monitoring
- Bloods: FBC, U&E, CRP, cultures (if sepsis)
- ECG and cardiac monitoring
- Regular inspection of the cannula site for blanching/swelling
Management
- Confirm shock and resuscitation target (MAP ≥65 mmHg) and that vasopressor is indicated now, not after central access
- Site a reliable ≥18-20G cannula in a large proximal vein (antecubital fossa or forearm), avoiding wrist, hand and foot; test with a flush
- Use diluted noradrenaline (e.g. 4 mg in 250 mL = 16 mcg/mL) via a volumetric pump with a dedicated lumen
- Start low and titrate to MAP ≥65 mmHg; reassess perfusion and lactate
- Inspect the site every 15-30 min and keep the limb visible; mark the vein
- Arrange central venous access within 6-24 h (or sooner if dose rising or run prolonged)
- If extravasation occurs, stop infusion, leave cannula, aspirate, and treat with phentolamine; escalate to central line
- Document indication, concentration, site and duration
Drugs & doses
Noradrenaline (peripheral) — 4 mg in 250 mL 0.9% saline (16 mcg/mL) IV, 0.05-0.5 mcg/kg/min titrated to MAP ≥65 mmHg; limit to <72 h or until central access
Phentolamine — 5-10 mg in 10-15 mL 0.9% saline infiltrated subcutaneously around the extravasation site (antidote)
Glyceryl trinitrate 2% ointment — 1-2 cm topically to ischaemic/blanched skin as an alternative/adjunct for extravasation
Disposition
Admit to a critical care or high-dependency area with a clear plan for timely central venous access and ongoing site surveillance.
Complications & pitfalls
- Extravasation causing skin and soft-tissue necrosis
- Digital/limb ischaemia
- Thrombophlebitis
- Delayed recognition of line failure with recurrent hypotension
- Compartment syndrome (large-volume extravasation)
Exam pearls
- Peripheral noradrenaline for a few hours is safer than hypoperfusion while awaiting a central line
- Proximal, large-vein, short-duration and vigilant monitoring are the key safety rules
- Keep phentolamine and GTN ointment immediately available wherever peripheral vasopressors run
- Most extravasation injuries occur with distal cannulae and concentrated preparations
Disclaimer: Educational decision support for qualified clinicians and students — not a substitute for clinical judgement, local protocols or a full drug reference. Confirm every dose and contraindication against your formulary before prescribing.